Eriko Takatori

0283695, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

Journal: Cancers

Published: March 09, 2026

Clinical utility of diagnostic laparoscopy for ovarian metastasis from breast cancer in a BRCA1-mutated patient with hereditary breast and ovarian cancer syndrome: a case report and literature review.

Clinical utility of diagnostic laparoscopy for ovarian metastasis from breast cancer in a BRCA1-mutated patient with hereditary breast and ovarian cancer syndrome: a case report and literature review.

Journal: International cancer conference journal

Published: February 25, 2026

Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study.

Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: January 16, 2026

Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.

Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.

Journal: International journal of clinical oncology

Published: October 27, 2025

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: October 23, 2025

Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment.

Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment.

Journal: International journal of clinical oncology

Published: October 20, 2025

Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study.

Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study.

Journal: Anticancer research

Published: September 20, 2025

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Journal: Cancers

Published: October 13, 2024

Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients.

Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients.

Journal: International journal of clinical oncology

Published: October 07, 2024

Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors.

Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors.

Journal: International journal of clinical oncology

Published: August 02, 2024

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

Journal: Cancers

Published: June 05, 2024

A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.

A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.

Journal: Japanese journal of clinical oncology

Published: August 31, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026